Related Experiment Videos
[Guideline satisfying therapy for chronic heart failure]
1Klinik III für Innere Medizin, Universitätsklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. Uta.Hoppe@uni-koeln.de
Insights
Standard treatments for systolic heart failure are effective, but evidence-based therapies for diastolic heart failure are lacking, leaving treatment largely empirical.
Area of Science:
- Cardiology
- Heart Failure Pathophysiology
- Pharmacotherapy
Context:
- Chronic heart failure presents as either systolic pump dysfunction or impaired diastolic ventricular filling.
- Current pharmacotherapy for systolic heart failure is well-established.
Purpose:
- To outline current therapeutic strategies for systolic heart failure.
- To highlight the limited evidence-based treatment options for diastolic heart failure.
Summary:
- Systolic heart failure management involves ACE inhibitors, beta-blockers, diuretics, and potentially aldosterone antagonists or AT1 receptor blockers.
- Biventricular pacing can improve symptoms and prognosis in severe systolic heart failure with cardiac dyssynchrony.
- Diastolic heart failure treatment relies primarily on empirical approaches due to a lack of clinical trial data.
Impact:
- Evidence-based treatments significantly reduce morbidity and mortality in systolic heart failure.
- The absence of clinical trial results for diastolic heart failure necessitates further research.
- Current therapeutic strategies for diastolic heart failure remain largely empirical, indicating a need for improved treatment guidelines.
Abstract:
Chronic heart failure may be caused by systolic pump failure and/or impairment of diastolic filling of the ventricles. The standard pharmacotherapy for systolic heart failure includes an ACE inhibitor, betablocker, diuretics and, in patients with severe symptoms, a low dose aldosterone antagonist. An AT1 receptor blocker is indicated for those patients who do not tolerate ACE inhibitors. If patients remain in the functional class NYHA III-IV despite optimal medication and have cardiac dyssynchrony, biventricular pacing may improve the symptoms and prognosis. While evidence-based treatment significantly reduces morbidity and mortality in systolic heart failure, hardly any results from clinical trials are available for diastolic heart failure. Therefore, therapy in patients with diastolic heart failure remains in most cases empirical.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System